Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

Br J Pharmacol. 1999 Feb;126(3):568-71. doi: 10.1038/sj.bjp.0702343.

Abstract

Using in vivo extracellular unitary recording, the effect of short term (2-day) and long-term (21-day) administration of the selective 5-HT reuptake inhibitor (SSRI) paroxetine (10 mg kg(-1) day(-1), s.c. using osmotic minipumps) was examined on the spontaneous firing activity of locus coeruleus noradrenergic neurons. Long-term but not short-term treatment significantly decreased firing activity. Thus, it appears that enhancing 5-HT neurotransmission by sustained SSRI administration leads to a reduction of the firing rate of noradrenergic neurons. The SSRI paroxetine therefore alters the activity of noradrenergic neurons with a delay that is consistent with its therapeutic action in depression and panic disorder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Citalopram / pharmacology
  • Evoked Potentials / drug effects*
  • Locus Coeruleus / drug effects
  • Locus Coeruleus / physiology
  • Male
  • Neurons / drug effects*
  • Neurons / physiology
  • Paroxetine / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Selective Serotonin Reuptake Inhibitors / pharmacology*

Substances

  • Serotonin Uptake Inhibitors
  • Citalopram
  • Paroxetine